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Introduction: Kiwifruit consumption has shown to improve functional constipation in healthy 
elderly population, according to studies in New Zealand and China. The aim of this study was 
to evaluate the effect of kiwifruit intake on functional constipation in a Mediterranean patient 
population characterized by its distinctive nutritional habits.
Material and Methods: An open, non-controlled and non-randomized longitudinal  study was 
conducted in 46 patients with constipation (Rome III criteria). Patients monitored for five weeks: 
weeks 1 and 2 no kiwifruit and weeks 3-5 three kiwifruit per day (Green kiwifruit, Actinidia 
deliciosa var Hayward). Bristol Scale, volume of stools, and ease of defecation was self- reported 
daily. The evolution of the categorical variables was tested using the Bhapkar test; functional 
data methodology was used for continuous variables, and Generalized Estimating Equation 
(GEE) models were adjusted. 
Results: The percentage of patients with ≥3 stools per week increased from 82.61% (95% CI: 69–91.2) 
at week 1 to 97.78% (95% CI: 87.4–99.9) at week 2 of kiwifruit intake, with 76.09% (95% CI: 
61.9–86.2) responding during the first week. The reporting of stable ideal stools increased 
from 17.39% (95% CI: 8.8–31) at week 2 to 33.33% (95% CI: 21.3–48) at week 5. According 
to GEE models, the number of depositions increased significantly (p-values<0.001) in 0.398 
daily units at week 1 the first week of intake, up to 0.593 daily units at week 5; significant 
improvements on facility in evacuation and volume of evacuation were found from the first 
week of intake (all p-values<0.001). 
Conclusions: The intake of three kiwifruits per day significantly improves the quality of 
evacuation (number of depositions, volume, consistency and ease) in a Mediterranean patient 
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Introducción: Consumir kiwi mejora el estreñimiento funcional en la población anciana sana de 
Nueva Zelanda y China. Nuestro objetivo es evaluar el efecto del kiwi en la población mediterránea 
con estreñimiento.
Material y métodos: Estudio prospectivo longitudinal no cegado no aleatorizado. 46 pacientes 
adultos con estreñimiento (criterios Roma-III) fueron seguidos durante cinco semanas: dos previas 
y tres durante la intervención (3 kiwi/día) (Green kiwifruit, Actinidia deliciosa var Hayward). 
Autoinforme diario del número de deposiciones, consistencia y volumen heces y facilidad de 
evacuación. La evolución de las variables categóricas se testó con el test Bhapkar, las variables 
continuas mediante metodología de análisis de datos funcionales ajustando modelos basados en 
las ecuaciones de estimación generalizadas (GEE).
Resultados: El porcentaje de pacientes con ≥3 deposiciones/semana aumentó de 82,61% 
(IC 95%: 69–91,2) en la primera semana hasta 97,78% (IC 95%: 87,4–99,9) al final de semana 
2 de consumo, con una respuesta del 76,09% (IC 95%: 61,9–86,2) en la primera semana. El 
porcentaje de heces consideradas ideales pasó de 17,39% (IC 95%: 8,8–31) en la segunda semana 
a 33,33% (IC 95%: 21,3–48) en la semana 5. Según los modelos GEE, el número de deposiciones 
aumenta significativamente (valor p<0,001) en 0,398 unidades diarias en la primera semana 
de consumo, hasta 0,593 unidades diarias en la última semana. A partir de la primera semana 
se observa mejoras significativas en el volumen de las heces y en la facilidad de la defecación 
(valores p<0,001). 
Conclusiones: Consumir tres kiwis al día mejora significativamente la calidad de la evacuación 
(número deposiciones, volumen, consistencia y facilidad evacuación), en una población 
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INTRODUCTION
CITA
Constipation is a symptom suffered by a large number of 
people, due to multifactorial causes. Worldwide general 
population prevalence of this symptom ranges from 0.7% 
to 79% (median 16%)1. Some factors associated with 
constipation are sex, with higher prevalence in females 
(especially during pregnancy)1, and age; in general it 
becomes gradually more prevalent after the 70 years of 
age, in women the increase is considerable from a young 
age (18–23 years old) to middle age (45–50 years old)1.
Although constipation frequently manifests itself during a 
limited time period and with a moderate impact on health, 
it represents a major problem not only because of its high 
prevalence but also for its personal, social, occupational 
and economic effects2. Both physical and mental impacts 
interfere with quality of life and personal wellbeing3. The 
costs of constipation healthcare and treatment are highly 
significant, consuming a large volume of resources, both in 
relation to the use of laxatives and to medical visits4 (even 
considering the large proportion of population that take 
medication without prescription)5.
Constipation is characterized by difficult or infrequent 
deposition, often accompanied by excessive straining during 
bowel movement or sensation of incomplete evacuation. 
In most cases, there is no underlying organic cause, and 
constipation is labelled as chronic idiopathic constipation 
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Setting: The study was conducted in five primary healthcare 
centres in Barcelona, Catalonia, Spain. 
Period Study: Between April and August 2013.
Population sample: Fifteen participating family doctors 
selected patients from the electronic medical records 
(e-HCAP) following inclusion and exclusion criteria. Each 
investigator was allowed to include a maximum of 4 patients. 
Forty-six subjects were selected for the study.
Sample calculation: According to results from Chang12, 
sample size was calculated to detect a change in the 
proportion of individuals with 3 or more defecation per 
week from 56% to 86% (evolution from an average of 3.2 
to 4.4 –stable Standard Deviation (SD) of 1.3– in a normal 
distribution). Assuming a bilateral contrast for paired data, 
with a significance level of 0.05 and power of 0.8, a sample 
of 44 individuals was required (covering a 10% of dropout 
rate).
Inclusion criteria: Adults (aged 18 to 65) with e-HCAP 
constipation diagnosis, following Rome-III criteria6:
• Two or more of the following: 
- Straining during at least 25% of defecations
- Lumpy or hard stools in at least 25% of defecations
- Sensation of incomplete evacuation for at least 25% 
of defecations 
- Sensation of anorectal obstruction/blockage for at 
least 25% of defecations
- Manual manoeuvres to facilitate at least 25% of 
defecations (e.g., digital evacuations and support of 
the pelvic floor)
- Fewer than three defecations per week; and 
• Loose stools are rarely present without the use of 
laxatives; 
• Insufficient criteria for irritable bowel syndrome; 
• Criteria fulfilled for at least 3 months with symptom 
onset at least 6 months before diagnosis.
Exclusion criteria: Patients with allergy to kiwifruit or 
latex; who have undergone gastro-intestinal surgery in 
the last year; taking medication to treat constipation; 
with oncological disease; taking narcotic medication or 
with organic gastroenterological diseases (except non-
complicated diverticulosis). 
and as a functional digestive disorder. The Rome-III criteria6 is 
a useful tool for the diagnosis of constipation that highlights 
the chronic nature of the disorder and the importance of 
symptoms beyond the infrequency of bowel movements. 
Understanding its causes, prevention, and treatment will help 
most people find constipation relief7. An individual’s medical 
history is very important in determining a constipation 
diagnosis. Primary healthcare professionals should enquire 
about dietary habits and lifestyle, pharmacological and 
toxic habits, complementary and alternative medicine, 
physiological bowel habits, use of laxatives and past disease 
history7.
There have been several small-randomized controlled 
trials (RCTs) studying the relationship between dietary 
fiber and constipation. A meta-analysis demonstrated that 
dietary fiber can increase stool frequency in patients with 
constipation but also showed that dietary fiber did not 
improve stool consistency, treatment success, laxative use 
and painful defecation8. On the consumption of fruits there 
are very few studies. A crossover RCT (40 patients) showed 
that dried plums 50g taken twice a day for 6 weeks, improve 
the number of stools per week and the score on the Bristol 
scale and improves symptoms associated with constipation 
and straining9.
A growing body of scientific evidence supports the 
consumption of green kiwifruit as a digestive aid, as it leads 
to more effective digestion of dietary protein, increased 
faecal bulking and softening and better lubrication that 
assists the propulsion of contents along the colon. Recent 
studies have demonstrated significant results in the 
treatment of constipation in healthy elderly10,11 in patients 
with irritable bowel syndrome12. These studies consistently 
report an increase in the frequency and ease of defecation, 
stool volume and softness. 
Although literature suggests that kiwifruit consumption 
improves constipation symptoms, no studies have been 
carried out in adults nor in a Mediterranean patient 
population, which are characterized by its distinctive 
nutritional habits. The aim of the present study was to test 
the effect of kiwifruit consumption on functional constipation 
in a Spanish adult population.  
Design: Open non-controlled and non-randomized 
longitudinal study, on the effect of kiwifruit consumption in 
adult patients with diagnosed constipation.
MATERIAL AND METHODS
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towards diarrhoea. The Bristol Scale is a scale translated, 
validated and adapted into Spanish14]. Volume of stool: very 
little (1), little (2), medium (3), reasonably much (4), a lot (5). 
Ease of defecation: very easy (1), easy (2), normal (3), difficult 
(4), very difficult (5). Patients answered eight satisfactions 
questions related to the improvement of defecation habits 
and quality of life. Other variables collected: use of laxatives, 
type of laxative, nutrition habits and special diets if present. 
All the variables were recorded in a daily basis, except the 
satisfaction of the patient that was recorded on a weekly 
basis. Other variables collected were age, gender, weight 
and height.
Tools and instructions: The five-week study design and 
associated activities are shown in the flow chart (Figure 1). 
Primary Care Professionals asked patients to participate in 
the study and explained it to them. Patients who voluntarily 
agreed to participate signed the informed consent, accepting 
all study procedures. Each participant in the study attended 
three consultations: the first one before starting the study, 
the second one after two weeks and the third one after five 
weeks. There was no follow-up period. 
Intervention: The duration of the study was five weeks. 
During the first two weeks patients were asked to follow 
their regular diet and avoid kiwifruit consumption. The 
next three weeks they were asked to consume three green 
kiwifruits (Actinidia deliciosa var Hayward) per day, one at 
each main meal (breakfast, lunch and dinner). Throughout 
the five-week study period the patient had to continue their 
normal eating habits and exercise regime.
Outcomes and their measurement: Primary endpoint: 
proportion of patients with three or more stools per week, 
frequency of stool per week and number of responders 
(increase of ≥1 stool per week). Secondary endpoints: 
Consistency of stool - Bristol Scale13: classified as Type 
1 (Separate hard lumps, like nuts-hard to pass), Type 2 
(Sausage-shaped, but lumpy), Type 3 (Like a sausage but 
with cracks on its surface), Type 4 (Like a sausage or snake, 
smooth and soft), Type 5 (Soft blobs with clear cut edges 
–passed easily–), Type 6 (Fluffy pieces with ragged edges, 
a mushy stool), or Type 7 (Watery, no solid pieces, entirely 
liquid). Types 1–2 indicate constipation, with 3 and 4 being 
the ideal stools (especially the latter), and 5-7 tending 
Figure 1. Flow chart.
* Ticket collection and payment of the amount could be agreed with the patient in different ways (every other day, weekly, etc...)
Selected adults (age 18 to 65) with e-HCAP 
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RESULTS
46 subjects participated in the study. 42 were women, 
with median age of 49.5 (IQR: [37.5, 56.7]), weight of 67kg 
(IQR: [59, 73]) and height of 160.0cm (IQR: [157.2, 165.0]). 
One participant abandoned the study due to bloating and 
abdominal pain. 
The percentage of patients with ≥3 stools per week increased 
from 82.61% (95% CI: 69–91,2) at week 1 to a maximum 
of 97.78% (95% CI: 87,4–99,9) at week 4 (second week of 
kiwifruit consumption; Table 1). The maximum number of 
responders (increase of ≥1 stool per week) was detected 
at the first week of kiwifruit consumption [76.09% 95% CI: 
61,9–86,2)]. The average increase of number of stools from 
first week to the fifth week was of 4.47 (IQR: [2, 7]).
Mean daily evolution in the Number of depositions, Facility in 
evacuation and Volume of evacuation (treated as continuous 
functional data) is shown in Figure 2. Daily Bristol Scale, 
Facility in evacuation and Volume of evacuation distributions 
are plotted categorically in Figure 3. The percentage 
of individuals with any Bristol evaluation below Type 3 
(constipation) decreased from 67.39% at week 2 to 35.56% 
at week 5; the variation in percentage of individuals with 
any Bristol evaluation beyond Type 4 (diarrhoea) increased 
from 26.09% to 44.44%. The percentage of individuals with 
ideal stools (Types 3 and 4) during all week increased from 
17.39% (95% CI: 8.8–31) at week 2 to 33.33% (95% CI: 21.3–
48) at week 5.
GEE models (Table 2) found statistically significant 
differences from week 2 for the three outcomes, concomitant 
with the beginning of the kiwifruit consumption. The daily 
Number of depositions increased from the 0.671 mean 
depositions at week 2 in 0.398 daily units at the first week 
To collect the information patients used a questionnaire 
designed ad hoc for a similar study conducted in Belgium 
(see Annex 1). The French original version of the diary 
was translated into Spanish and Catalan. The family 
doctors provided instructions on the recording of faecal 
characteristics. Patients chose their own language to 
respond. Investigators collected data from diaries in a 
Google Docs form.
Patients were supplied with kiwifruit by different ways. Some 
patients in the study bought the prescribed product. In 
other cases it was the investigator who provided kiwifruits. 
In one of the Primary Care Centres, the neighbourhood 
shopkeeper was the responsible for delivering kiwifruits to 
the patients. Patients who bought their own kiwifruit (Zespri) 
were refunded. 
Statistical analysis: Demographics for patients were 
summarized calculating medians [Interquartile Range (IQR)] 
for continuous variables and proportions for categorical 
variables. Categorical variables were compared from 
baseline (second week) to last week using the Bhapkar test. 
For some analyses, Facility and Volume categorical variables 
were treated as continuous in order to provide results easy 
to interpret and taking into account individuals’ correlations; 
in these cases, one unit of gain should be interpreted as an 
improvement in one response category. Functional data 
methodology was used for some graphical representations. 
Stacked bar plots over time will be presented for categorical 
variables. To analyse week changes in daily variables 
Generalized Estimating Equation (GEE) models were 
adjusted15,16 (treating variables as continuous).
Ethics committee: The study protocol was submitted to the 
ethics committee of the IDIAP Jordi Gol i Gurina Foundation 
(http://www.idiapjgol.org/). 
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Figure 2. Evolution of daily outcomes (with 95% confidence intervals).
Table 2. Generalized Estimating Equation (GEE) estimations on the week effect on number of depositions, facility in 

















































Second week was taken as the reference; the other coefficients are differences in relation to second week. 
GEE model for the number of depositions used the poisson link function; marginal effect was obtained as β exp (Xβ).
at week 2 (p-value<0.001). The Volume of evacuation 
evaluation improved in 0.29 levels in average at the third 
week of kiwifruit consumption (p-value<0.001).
of kiwifruit consumption, and in 0.593 daily units at week 
5 (both p-values<0.001). Evaluation of Facility in evacuation 
improved in 0.674 levels in average at the last week of 
follow-up in relation to the mean 2.702 score (p<0.001) 
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Figure 3. Daily distribution of Bristol Scale, Facility in evacuation, and Volume of evacuation.
Bristol Scale presents type 1 as the lowest category and type 7 as the highest (both in red). Facility in evacuation categories are 
“Very difficult” (red), “Difficult”, “Normal”, “Easy”, and “Very easy” (green at top). Volume of evacuation categories are “Very little” 
(lower orange), “Little”, “Neither a little nor a lot”, “A lot”, “Abundant”, “Very abundant” (upper orange).
(1,1 - 1,3): (First digit: week, second digit: day)
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The study controlled for baseline use of laxatives. 
Categorical longitudinal data should suitably be fit using 
multinomial logit models with random effects; however, 
the implementation of such models in statistical software is 
still not solidly established. In our study, ordinal categories 
were treated as continuous variables using GEE models, 
as multinomial logit models with random effects did not 
converge in our data (using MCMC methods). Results of our 
GEE models for these ordinal variables should be carefully 
interpreted taking into account the underlying nature of 
these variables. 
The benefits of this intervention could go beyond the 
consumption of kiwifruit itself. It is noticeable that in the 
second week (still before intervention) patients started 
reporting a slight non-significant improvement of the 
results. Although not being statistically significant, this 
could suggest a change in other related habits and lifestyles 
just because of being part of the study, which could have 
slightly influenced study outcomes.
Despite these limitations, the study has its strengths. A huge 
effort was done in order to ensure adherence and compliance. 
Given the low-income profile of some participants, centres 
facilitated the process offering different alternatives: 
daily distribution of kiwifruit in the Primary Care Centre, 
distribution of kiwifruit by the neighbourhood store, etc. 
Participants once included in the study had two follow-up 
visits and were followed about taking laxatives, taken food 
and exercise. No significant changes were detected in these 
three aspects, although a lower consumption of laxatives 
was observed during the five weeks of follow up.
Data recording by family doctors using Google Docs form 
provided a good quality database for analysis. Moreover, 
given the small number of patients per investigator, in case 
of doubts on the completion of the diary, data was confirmed 
during the upcoming medical follow-up visits. 
It would be interesting to assess whether similar results 
can also be achieved by taking one or two kiwifruit per day. 
On the other hand, the notable psychological impact of 
constipation is a major issue for many patients; therefore, 
the impact of consuming kiwifruit on other aspects (i.e. 
healthy habits, quality of life) would provide a holistic 
view of the real impact of kiwifruit consumption on health. 
Further research is needed to improve our knowledge on 
the benefits of kiwifruit on constipation and other health 
parameters through a RCT.
Although the laxative effect of fruit has been attributed to 
its relatively high content of fibre (about 3.4g per 100g of 
edible pulp), other kiwi phytonutrients are important not 
only to maintain a healthy intestinal regularity but also to 
Differences in the satisfaction evaluations between the 
second week and the fifth week were found statistically 
significant –according to Bhapkar tests– for bloating and 
swelling (p<0.001), urgent need to defecate (p=0.007), 
irritable mood (p<0.001), stool number (p<0.001), stool 
consistency (p<0.001), and enough stools (p=0.031). 
Changes in giving up activities (p=0.243) were not significant; 
while changes in stomach ache (p=0.052) did not reach the 
0.05 threshold.
In this study, the global weekly evolution of the primary 
endpoints (Number of depositions per week, percentage of the 
patients with no constipation and number of responders) 
after kiwifruit consumption in Mediterranean patients 
suffering from constipation provided positive results. The 
evolution of daily outcomes (Number of depositions, Facility 
in evacuation, Volume of evacuation, and Bristol Scale) also 
had positive results. Most people in the study were women, 
which reflects the higher prevalence of constipation 
amongst them. These results allow us to conclude that 
increasing dietary fibre consumption in terms of kiwifruit 
improves constipation symptoms in a Mediterranean patient 
population. Furthermore, these results allow us to think that 
if kiwifruit consumption were maintained over time, possibly 
many people with a constipation diagnosis would not meet 
the diagnostic criteria of Rome-III constipation.
Our results are aligned to those of previous studies. 
Although New Zealand and Chinese studies present major 
differences in design (number of kiwis –1kw/30kg weight–, 
or twice a day) and population (elderly, volunteers), results 
also showed a significant improvement of symptoms10,11.
Results must be interpreted in light of the following 
limitations. Firstly, and most important a pre-post design 
without parallel controls is subject to bias, e.g. as regression 
to the mean. Likewise the fact that patients and physicians 
were not blinded and the short follow-up study period.
In addition, two patients abandoned the study prior to the 
kiwifruit intervention and one participant had to abandon 
the study due to bloating and abdominal pain; two new 
patients replaced the latter two patients, while the third 
patient was not replaced. Although respondents found 
questionnaires easy to complete, some limitations were 
detected; specifically, only one faecal evaluation was allowed 
per day, thereby not allowing coding cases where the 
number of stools per day was greater than one and the fact 
that responses to the self-perception of bowel movements 
could influence the outcomes.
DISCUSSION
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